Winton Group’s Prelude Therapeutics PRLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$76.2K Buy
+19,500
New +$95.6K ﹤0.01% 1050

Other funds holding PRLD

Winton Group's PRLD Position: Q3 2026 in Review

Winton Group opened a new position in Prelude Therapeutics (PRLD) in Q3 2026: 19,500 shares worth $76.2K. The stake represents ﹤0.01% of the portfolio and ranks #1050 among its holdings.

90 funds tracked by Wall St. Rank hold PRLD as of Q3 2026.

  • Winton Group held 19,500 shares of Prelude Therapeutics worth $76.2K as of Q3 2026.
  • Prelude Therapeutics was a new Winton Group position in Q3 2026.
  • Prelude Therapeutics made up ﹤0.01% of Winton Group's portfolio in Q3 2026, its #1050 holding.
  • 90 funds tracked by Wall St. Rank held Prelude Therapeutics as of Q3 2026.

Based on Winton Group's 13F filing for Q3 2026, filed 12 Nov 2026.